BOSTON--(BUSINESS WIRE)--PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Third Quarter Fiscal Year 2017 on Wednesday, May 3, 2017 after the close of the stock market.
PAREXEL will host a conference call and live webcast at 10:00 a.m. ET on Thursday, May 4, 2017 to discuss the results. To access the webcast, visit the Investor Section of PAREXEL’s website at www.PAREXEL.com. This webcast will continue to be accessible for one year following the live broadcast. To participate via telephone, dial (408) 940-3886 and ask to join PAREXEL’s Third Quarter Fiscal Year 2017 conference call.
About PAREXEL International
PAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of expertise-based clinical research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, and reimbursement. PAREXEL Informatics provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL has offices in 85 locations in 51 countries around the world, and had approximately 18,625 employees in the second quarter. For more information about PAREXEL International visit www.PAREXEL.com.